Neuroprotection: a new strategy in the treatment of schizophrenia. Neurobiological basis of neurodegeneration and neuroprotection.

CNS spectrums

Volumn 12, Issue 10 Suppl 18, 2007, Pages 4-6

  Lieberman, Jeffrey A ^a  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPROTECTIVE AGENT;

APOPTOSIS; BRAIN; DRUG EFFECT; HUMAN; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

APOPTOSIS; BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EID: 62449264425     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)